by Owkin
Owkin builds K Pro, an AI scientist for biomedical research that works with pharma R&D teams. It draws on a network of multimodal patient data and wet lab validation.
Web appContact for pricing
Step 1: Book a demo through the Owkin site.
Step 2: Discuss your research questions and therapeutic area with the Owkin team.
Step 3: Put the questions to K Pro, which orchestrates its agents, tools and skills across the data.
Step 4: Review the output with your scientists and refine hypotheses.
Step 5: Send promising hypotheses for validation through Owkin's wet lab and biomedical experts.
K Pro is Owkin's AI scientist for biology. It combines biological language models, multimodal patient data and AI tools to support drug discovery decisions.
The site says four large pharma companies use it today: AstraZeneca, Sanofi, Servier and Boehringer Ingelheim.
The site directs visitors to book a demo with the Owkin team. It does not list public plans or prices.
Its about page lists CE marked diagnostics developed through its spin out Waiv, including tools for breast and colorectal cancer.
BigHat BiosciencesBigHat Biosciences is a clinical-stage biotech that combines AI with an automated lab to design antibody therapeutics. Its Milliner platform generates the data used to train and improve its models.
DistillerSR AIDistillerSR AI uses AI for AI-assisted systematic literature review platform for screening, data extraction, evidence management, and regulatory research.